{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:59:18Z","timestamp":1790657958475,"version":"4.1.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pseudomyogenic hemangioendothelioma (PHE) is a rare vascular neoplasm of intermediate malignant potential that predominantly affects young adult men and most frequently arises in the lower extremities. Involvement of unusual skeletal sites is uncommon, and the nonspecific imaging features of PHE may contribute to diagnostic uncertainty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case report<\/jats:title>\n                    <jats:p>We report three cases of PHE involving unusual osseous locations, including the thoracic spine, femur, and humerus, with one case showing concomitant soft tissue involvement of the upper arm. Multimodal imaging, including computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography\/computed tomography (PET\/CT), demonstrated osteolytic bone destruction, soft tissue extension, heterogeneous enhancement, and increased metabolic activity. All patients underwent individualized surgical management according to tumor location and disease extent. The final diagnosis was established by histopathological and immunohistochemical (IHC) evaluation, particularly FOSB positivity and endothelial marker expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PHE should be considered in the differential diagnosis of atypical bone and soft tissue lesions, even when they occur at uncommon anatomic sites or in patients outside the typical demographic profile. Comprehensive imaging assessment, histopathological confirmation, individualized treatment, and long-term follow-up are essential for accurate diagnosis and optimal clinical management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1934676","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:41:34Z","timestamp":1790656894000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Three rare cases of pseudomyogenic hemangioendothelioma with atypical skeletal involvement"],"prefix":"10.3389","volume":"13","author":[{"given":"Meizheng","family":"Dang","sequence":"first","affiliation":[{"name":"Department of Ultrasound in Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buyi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Second Affiliated Hospital of Zhejiang University School of Medicine","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Ultrasound in Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pintong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound in Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13000-019-0857-6","article-title":"A rare case of pseudomyogenic hemangioendothelioma (PHE)\/epithelioid sarcoma-like hemangioendothelioma (ES-H) of the breast first misdiagnosed as metaplastic carcinoma by FNAB and review of the literature","volume":"14","author":"Ge","year":"2019","journal-title":"Diagn Pathol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/00000478-200301000-00006","article-title":"Epithelioid sarcoma-like hemangioendothelioma","volume":"27","author":"Billings","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/PAS.0b013e3181ff0901","article-title":"Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior","volume":"35","author":"Hornick","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.5858\/arpa.2018-0395-RS","article-title":"Pseudomyogenic hemangioendothelioma (epithelioid sarcoma-like hemangioendothelioma)","volume":"144","author":"Caballero","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/cup.12196","article-title":"Epithelioid sarcoma-like (pseudomyogenic) hemangioendothelioma, clinically mimicking dermatofibroma, diagnosed by skin biopsy in a 30-year-old man","volume":"40","author":"Stuart","year":"2013","journal-title":"J Cutan Pathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/PAS.0000000000000795","article-title":"FOSB is a useful diagnostic marker for pseudomyogenic hemangioendothelioma","volume":"41","author":"Hung","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/RLU.0000000000001625","article-title":"Lower-extremity pseudomyogenic hemangioendothelioma on bone scintigraphy and PET\/CT","volume":"42","author":"Krebs","year":"2017","journal-title":"Clin Nucl Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.radcr.2019.06.029","article-title":"Pseudomyogenic hemangioendothelioma-a case report and review of the literature","volume":"14","author":"Dianat","year":"2019","journal-title":"Radiol Case Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00256-013-1577-8","article-title":"Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma: characterization of five cases","volume":"42","author":"Amary","year":"2013","journal-title":"Skeletal Radiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1097\/PAS.0000000000001147","article-title":"Expanding the spectrum of genetic alterations in pseudomyogenic hemangioendothelioma with recurrent novel ACTB-FOSB gene fusions","volume":"42","author":"Agaram","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/path.4322","article-title":"A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma","volume":"232","author":"Walther","year":"2014","journal-title":"J Pathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.21873\/cgp.20134","article-title":"Fusion of the genes WWTR1 and FOSB in pseudomyogenic hemangioendothelioma","volume":"16","author":"Panagopoulos","year":"2019","journal-title":"Cancer Genom Proteom"},{"key":"B13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/gcc.22891","article-title":"A novel CLTC-FOSB gene fusion in pseudomyogenic hemangioendothelioma of bone","volume":"60","author":"Bridge","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/cac2.12020","article-title":"Clinicopathological features of pseudomyogenic hemangioendothelioma and precision therapy based on whole exome sequencing","volume":"40","author":"Wei","year":"2020","journal-title":"Cancer Commun (Lond)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/PAS.0000000000000613","article-title":"Primary pseudomyogenic hemangioendothelioma of bone","volume":"40","author":"Inyang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11657-022-01062-4","article-title":"Pseudomyogenic hemangioendothelioma with bone and soft tissue involvement with favorable response to pamidronate: a case report and systematic review of the literature","volume":"17","author":"Brance","year":"2022","journal-title":"Arch Osteoporos"},{"key":"B17","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/PAS.0b013e3181882c54","article-title":"Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma","volume":"33","author":"Hornick","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/PAS.0000000000000511","article-title":"Nuclear expression of CAMTA1 distinguishes epithelioid hemangioendothelioma from histologic mimics","volume":"40","author":"Doyle","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1186\/s12885-019-6072-8","article-title":"Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report","volume":"19","author":"Otani","year":"2019","journal-title":"BMC Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"eRC1107","DOI":"10.31744\/einstein_journal\/2024RC1107","article-title":"Beyond the rare: a case of pseudomyogenic hemangioendothelioma treated sequentially with everolimus, denosumab, and pazopanib","volume":"22","author":"Silva","year":"2024","journal-title":"Einstein (Sao Paulo)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00256-015-2168-7","article-title":"An aggressive case of pseudomyogenic haemangioendothelioma of bone with pathological fracture and rapidly progressive pulmonary metastatic disease: case report and review of the literature","volume":"44","author":"Shah","year":"2015","journal-title":"Skeletal Radiol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1934676\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:41:59Z","timestamp":1790656919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1934676\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":21,"alternative-id":["10.3389\/fmed.2026.1934676"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1934676","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"article-number":"1934676"}}